StockWatch
·
Filing
Q3

Rossari Biotech Ltd

ROSSARIFY2521 Jan 2025
Revenue+2.9%
Net Profit-9.5%
OPM3.56%

P&L

Quarterly Consolidated

Revenue
+2.9%512.73
Expenditure
+4.4%471.23
Net Profit
-9.5%31.70
NPM 6.11%EPS ₹5.73+795.3%

vs Q2 FY25

Rossari Biotech Reports 10.5% Revenue Growth in Q3 FY25; PAT Down 7.8%

23 Jan 2025 · 23 Jan 2025, 02:01 am

Summary

Rossari Biotech Limited, a Specialty-Chemicals manufacturer, has announced its financial results for the quarter ended December 31, 2024. The company reported a 10.5% increase in revenue from operations to Rs. 512.7 crore, compared to Rs. 463.8 crore in Q3 FY24. However, the Profit After Tax (PAT) decreased by 7.8% to Rs. 31.7 crore from Rs. 34.4 crore in the same period last year. The company's gross margins improved due to a favorable product mix and operational efficiencies, but EBITDA margins were slightly lower due to ongoing investments in future initiatives.

Key Highlights

  1. 1

    Revenue from operations grew 10.5% to Rs. 512.7 crore

  2. 2

    EBITDA improved by 1.7% to Rs. 64.8 crore

  3. 3

    EBITDA margin at 12.6% as against 13.7%

  4. 4

    PAT decreased by 7.8% to Rs. 31.7 crore

  5. 5

    International business registered a Y-o-Y growth of 21% during the quarter

Management Comments

M

Mr. Edward Menezes

Promoter & Executive Chairman

We have navigated a dynamic operating environment in Q3 FY25, delivering resilient performance despite softer domestic market conditions. All business segments registered Y-o-Y volume growth during the quarter, with exports playing a pivotal role in driving overall performance amidst domestic challenges. During the quarter, HPPC grew by 10%, TSC by 15%, and AHN by 12% Y-o-Y, reflecting the dedicated efforts of our team in a challenging business environment. We have continued to target customers in both new and existing geographies, delivering strong performance in international markets. Our international business registered a Y-o-Y growth of 21% during the quarter and for the nine months, grew by 28%, providing support to overall performance amidst softer domestic growth. By targeting key markets, investing in technology, enhancing capacities, and introducing innovative products, we consistently strengthen our global footprint and position ourselves for sustained growth.

M

Mr. Sunil Chari

Promoter & Managing Director

Our gross margins improved during the quarter, supported by a favorable product mix and operational efficiencies. However, EBITDA margins were slightly lower this quarter due to ongoing investments in future initiatives. Despite this, we remain confident that higher operating leverage will enable us to improve margins over time. New capacities are expected to be commissioned soon, with projects being rolled out in a phased manner over the coming quarters. These expansions will further strengthen our ability to serve high-growth segments effectively. Innovation and sustainability remain at the core of our strategy as we pioneer intelligent, eco-friendly solutions tailored to evolving customer needs. Supported by robust R&D capabilities and a strong focus on operational excellence, we are well-equipped to capitalize on emerging opportunities and drive long- term growth. Our agile manufacturing setup and diversified product portfolio provide a strong foundation for delivering sustainable value to all our stakeholders.

Informational and educational content only. Not investment advice.